In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia

Author: Üstün C.   Beksac M.   Dalva K.   Koc H.   Konuk N.   Ilhan O.   Özcan M.   Topcuoglu P.   Sertkaya D.   Hayran M.  

Publisher: Humana Press, Inc

ISSN: 1357-0560

Source: Medical Oncology, Vol.19, Iss.1, 2002-03, pp. : 59-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content